Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.23EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.23NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.23NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.2.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.23NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.2.44EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.44NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
BA.5.2.44NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.5.2.44NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.44NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BN.1.3.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.3.9NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BN.1.3.9NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BN.1.3.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3.9NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BQ.1.1.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.8NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.8NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BQ.1.1.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.8NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
DV.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.6NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
DV.6NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
DV.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.6NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2 (Omicron)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2 (Omicron)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2 (Omicron)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.2 (Omicron)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2 (Omicron)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.5.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.5.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.5.5.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.5.5.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.5.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
CH.1.1.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.1.1.6NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CH.1.1.6NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
CH.1.1.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.6NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
CH.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.1.1.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CH.1.1.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
CH.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used